Where Iovance Biotherapeutics Stands With Analysts
Portfolio Pulse from Benzinga Insights
Analysts have provided bullish ratings for Iovance Biotherapeutics (NASDAQ:IOVA) within the last quarter, with an average price target of $28.3 versus the current price of $5.5. This average has increased by 1.07% from the previous average price target of $28.00.
September 13, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bullish analyst ratings and a significantly higher price target suggest potential upside for Iovance Biotherapeutics.
The bullish ratings from analysts and a higher price target compared to the current price indicate a positive outlook for Iovance Biotherapeutics. This could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100